DE60335202D1 - Chaperonin-10-immunosuppression - Google Patents

Chaperonin-10-immunosuppression

Info

Publication number
DE60335202D1
DE60335202D1 DE60335202T DE60335202T DE60335202D1 DE 60335202 D1 DE60335202 D1 DE 60335202D1 DE 60335202 T DE60335202 T DE 60335202T DE 60335202 T DE60335202 T DE 60335202T DE 60335202 D1 DE60335202 D1 DE 60335202D1
Authority
DE
Germany
Prior art keywords
donor
recipient animal
cpn10
administration
host disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60335202T
Other languages
German (de)
English (en)
Inventor
Geoffrey R Hill
Tatjana Banovic
Halle Coorparoo Morton
Alice Christina Cavanagh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CBio Ltd
Original Assignee
CBio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CBio Ltd filed Critical CBio Ltd
Application granted granted Critical
Publication of DE60335202D1 publication Critical patent/DE60335202D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60335202T 2002-11-06 2003-11-06 Chaperonin-10-immunosuppression Expired - Lifetime DE60335202D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2002952492A AU2002952492A0 (en) 2002-11-06 2002-11-06 Chaperonin 10 immunosuppression
PCT/AU2003/001467 WO2004041300A1 (en) 2002-11-06 2003-11-06 Chaperonin 10 immunosuppression

Publications (1)

Publication Number Publication Date
DE60335202D1 true DE60335202D1 (en) 2011-01-13

Family

ID=28795882

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60335202T Expired - Lifetime DE60335202D1 (en) 2002-11-06 2003-11-06 Chaperonin-10-immunosuppression

Country Status (16)

Country Link
US (3) US7618935B2 (enExample)
EP (3) EP2818179A1 (enExample)
JP (2) JP4716731B2 (enExample)
KR (1) KR101088740B1 (enExample)
CN (1) CN100525832C (enExample)
AT (1) ATE489963T1 (enExample)
AU (1) AU2002952492A0 (enExample)
CA (1) CA2505141C (enExample)
CY (1) CY1110972T1 (enExample)
DE (1) DE60335202D1 (enExample)
DK (1) DK1569679T3 (enExample)
ES (1) ES2351993T3 (enExample)
NZ (1) NZ540433A (enExample)
PT (1) PT1569679E (enExample)
SI (1) SI1569679T1 (enExample)
WO (1) WO2004041300A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005067959A1 (en) * 2004-01-16 2005-07-28 Cbio Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
AU2005204979B2 (en) * 2004-01-16 2010-10-21 Cbio Limited Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
US8036710B2 (en) * 2004-05-07 2011-10-11 Qualcomm, Incorporated Power-efficient multi-antenna wireless device
AU2006269824B2 (en) * 2005-07-11 2012-04-19 Cbio Limited Chaperonin 10-induced immunomodulation
BRPI0613515A2 (pt) * 2005-07-11 2011-01-11 Cbio Ltd imunomodulação induzida por chaperonina 10
BRPI0615284A2 (pt) 2005-08-31 2011-05-17 Cbio Ltd chaperonina 10 modificada
EP1951282A4 (en) * 2005-10-20 2009-09-02 Cbio Ltd TREATMENT OF HYPERSENSITIVITY
AU2006303826B2 (en) * 2005-10-20 2012-07-19 Cbio Limited Treatment of hypersensitivity
CN101443032A (zh) 2006-03-02 2009-05-27 悉生物有限公司 通过调节抗原呈递细胞的功能调节免疫反应
NZ588467A (en) * 2008-04-11 2012-11-30 Cbio Ltd Modified chaperonin 10 (CPN10) polypeptides and pattern recognition receptor (PRR) signalling
US20110243921A1 (en) * 2010-03-30 2011-10-06 Cbio Limited Prevention and treatment of cutaneous lupus erythematosus
WO2013158959A1 (en) * 2012-04-19 2013-10-24 Tarix Pharmaceuticals Ltd. Compositions and methods for treatment of graft-versus-host disease
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
KR102239867B1 (ko) 2012-12-10 2021-04-13 앨러간 파마슈티컬스 인터내셔널 리미티드 확장 가능한 3-차원 탄성 구조물 제조
KR102488446B1 (ko) 2013-08-13 2023-01-13 앨러간 파마슈티컬스 인터내셔널 리미티드 손상 조직의 재생

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2176948C (en) * 1993-11-30 2007-05-15 Halle Morton Chaperonin 10
ATE282634T1 (de) * 1993-11-30 2004-12-15 Univ Queensland Chaperonin 10
US5989804A (en) * 1994-07-08 1999-11-23 New England Medical Center Hospitals, Inc. E6 binding proteins
JPH11510806A (ja) * 1995-08-09 1999-09-21 シェーリング コーポレイション 免疫抑制治療のためのインターロイキン１０およびシクロスポリンの併用
US20020142000A1 (en) * 1999-01-15 2002-10-03 Digan Mary Ellen Anti-CD3 immunotoxins and therapeutic uses therefor
AU7361900A (en) * 1999-09-10 2001-04-10 Fordham University Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins
GB0028122D0 (en) * 2000-11-17 2001-01-03 St Georges Entpr Ltd Method

Also Published As

Publication number Publication date
CA2505141A1 (en) 2004-05-21
US20120082690A1 (en) 2012-04-05
EP1569679B1 (en) 2010-12-01
EP1569679A1 (en) 2005-09-07
EP2255824A1 (en) 2010-12-01
KR101088740B1 (ko) 2011-12-01
NZ540433A (en) 2008-03-28
CA2505141C (en) 2012-07-17
ES2351993T3 (es) 2011-02-14
EP2818179A1 (en) 2014-12-31
JP2006508099A (ja) 2006-03-09
CN1735428A (zh) 2006-02-15
PT1569679E (pt) 2010-12-14
DK1569679T3 (da) 2011-01-10
EP1569679A4 (en) 2008-02-27
JP4716731B2 (ja) 2011-07-06
US20060198834A1 (en) 2006-09-07
US20100099605A1 (en) 2010-04-22
CN100525832C (zh) 2009-08-12
US8067361B2 (en) 2011-11-29
SI1569679T1 (sl) 2011-01-31
CY1110972T1 (el) 2015-06-11
AU2002952492A0 (en) 2002-11-21
US7618935B2 (en) 2009-11-17
EP2255824B1 (en) 2014-07-23
ATE489963T1 (de) 2010-12-15
WO2004041300A1 (en) 2004-05-21
JP2011088920A (ja) 2011-05-06
KR20050086428A (ko) 2005-08-30

Similar Documents

Publication Publication Date Title
CY1110972T1 (el) Ανοσοκαταστολη με σαπερονινη 10
PT2163614T (pt) Animais porcinos que carecem de qualquer expressão de alfa 1,3 galactosiltransferase funcional
EP1487431A4 (en) PREVENTING AND / OR TREATING CARDIOVASCULAR DISEASE AND / OR RELATED CARDIAC INSUFFICIENCY
WO2002022184A3 (en) Bioengineered flat sheet graft prosthesis and its use
IS4409A (is) Notkun á kítósan og fjölsykru í tengslum við endurmyndun á hörðum vef, ásamt ígræðlingi
WO2004087006A3 (en) Implant delivery technologies
BR0203650A (pt) Estentor de auto-articulação
YU97402A (sh) Koštana (transkutalna) proteza
WO2007076508A3 (en) Implantable graft material
WO1999062425A3 (en) Bioengineered vascular graft prostheses
SI1546088T1 (sl) Spojine za uporabo v zdravljenju avtoimunskih bolezni, imunoalergijskih bolezni in zavrnitve transpalantata organa ali tkiva
EP1688425A3 (en) Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases
WO2004039248A3 (en) Repairing or replacing tissues or organs
AU2003222513A1 (en) Preventing and/or treating vascular disease, cardiomyopathy and/or associated heart failure
WO2001068828A3 (en) Compositions and methods for regulated protein expression in gut
SI1567171T1 (sl) Uporaba dekstran sulfata za zdravljenje IBMIR
BR9612821A (pt) Métodos para a prevenção de rejeição de enxerto em transplante e para a produção de uma célula de hospedeiro para terapia genética universal
WO2003102162A3 (en) Novel tolerogenic dendritic cells and therapeutic uses therefor
WO2005058280A3 (en) Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
WO2005041877A3 (en) Method of inhibiting rejection following organ transplantation
DE60023034D1 (en) Cd45 hemmer
WO2006121521A3 (en) Soft tissue implants, anti-scarring agents, and therapeutic compositions
BG104258A (en) 4-cyano-4-deformylsordarin derivatives
HUP0103107A2 (hu) Allogénikus és xenogénikus T-sejtek ex vivo kezelése gp39 antagonistákkal
NO20016326D0 (no) Anvendelse av proteinet UK 114 for å hindre avstötning av organtransplantatet